1. At a Glance
Let’s start with the kind of headline that would make any doctor proud: Unihealth Hospitals Ltd just reported a195% YoY jump in profits, a sizzling48% operating margin, and a120% stock return in the last three months. Not bad for a company that began as a medical tour operator and now manages hospitals acrossUganda, Nigeria, and Tanzania, while building a healthcare empire back home in India.
At amarket cap of ₹549 crore, Unihealth is what happens when a bunch of desi doctors and consultants decided that Africa deserves better hospitals — and that they deserve better valuations. Thecurrent price sits at ₹354, up from ₹120 just six months ago, leaving early investors feeling like they found the vaccine for bad returns. Thestock P/E stands at 22.8, quite a steal compared to the 56x median P/E of Indian hospital peers like Apollo and Fortis.
The latest H1FY26 results read like a health check-up report of a marathon runner:Revenue up 55% to ₹70 crore,EBITDA ₹35 crore, andnet profit ₹28.6 crore. With the newNavi Mumbai hospital operationalandNashik 200-bed facilitylaunching in early 2026, Unihealth seems to be running an Indo-African relay race — and so far, they’re winning every lap.
2. Introduction
Every once in a while, the Indian SME space produces a story so cinematic that even Netflix would call it “too optimistic.” Unihealth Hospitals Ltd is one of those rare cross-border healthcare adventures — a company that somehow manages to run hospitals in Africa, ship pharmaceuticals from India, and still find time to plan new hospitals faster than you can say “ICU.”
Founded in2010 in Mumbai, Unihealth began as amedical tour operator— basically arranging treatments in India for foreign patients who preferred a flight to Mumbai over a long wait in Kampala. Fast forward to 2025, and they’re not just arranging treatments; they’re running the hospitals themselves under the“UMC” brand— short for Unihealth Medical Centre.
They now operate inUganda, Nigeria, and Tanzania, with over200 hospital bedsand more than1.3 lakh patients treated annually. And just when you think this was an Africa-only play, they’ve decided to go full desi again with plans to buildfive new hospitals across Western India.
You know how Bollywood has “Desi Boyz”? Well, this is “Desi Docs,” featuring board-certified MBAs, African partnerships, and a storyline that’s part healthcare revolution, part startup hustle.
3. Business Model – WTF Do They Even Do?
Unihealth’s business model is like a thali — everything’s on the plate, and somehow, it works beautifully together.
1. Hospitals & Medical Centres (82% of FY25 revenue):This is the main course. Unihealth runsUMC Victoria Hospital (120 beds, Uganda),UMC Zhahir Hospital (80 beds, Nigeria), and adialysis facility in Tanzania. It’s not Apollo yet, but give it time — margins already rival them at 43% OPM.
2. Pharma Exports (8.5%):Through its subsidiaryUnihealth Pharmaceuticals Pvt Ltd, it distributes medical consumables and pharma products across Africa, including brands likeReliance LifesciencesandLevram Lifesciences.
3. Healthcare Consultancy (4.5%):The company advises other hospitals on project design, architecture, and setup — like a doctor who also sells the hospital blueprint.
4. Medical Value Travel:Still true to its roots, Unihealth facilitates international patient travel to India through tie-ups withMyanmar AirwaysandEthiopian Airlines.
5. Other Income (5%):Because why not? A healthy mix of interest income, service fees, and rent.
So yes — they treat patients, build hospitals, supply consumables, and run consulting gigs. Think of it as theInfosys of Healthcare, except instead of coding bugs, they’re fixing bones.
4. Financials Overview (Quarterly Data – ₹ in Crores)
| Metric | Latest Qtr (Sep 25) | Same Qtr Last Year (Sep 24) | Prev Qtr (Mar 25) | YoY % | QoQ % |
|---|---|---|---|---|---|
| Revenue | 66.7 | 43.3 | 56.0 | 54.1% | 19.1% |
| EBITDA | 32.0 | 15.0 | 21.0 | 113% | 52.4% |
| PAT | 15.1 | 5.1 | 8.0 | 195% | 88.8% |
| EPS (₹) | 9.75 | 3.30 | 5.10 | 195% | 91.2% |
Reporting Type:Quarterly (H1FY26 = Sep’25).
Annualised EPS = ₹9.75 × 4
= ₹39.0At CMP ₹354, that’s aP/E of ~9.1x annualised earnings. Even with a hospital gown on, that valuation looks healthy.
Commentary:Unihealth is literally minting profits from African operations while the rest of the sector is still fighting for OPD footfalls.EBITDA margin expanded to 48%, meaning every rupee of cost is working like it’s on steroids.
5. Valuation Discussion – The Fair Value Range
Let’s play valuation doctor.
(a) P/E Based:
- Annualised EPS = ₹39.0
- Sector P/E = 56 (median hospital sector)
- Even if Unihealth trades at half the industry multiple (28x), fair value = 28 × 39 =₹1,092 per share
- Conservative range =₹350–₹1,100
(b) EV/EBITDA Method:
- EV = ₹558 crore
- EBITDA (TTM) = ₹53 crore
- EV/EBITDA = 10.5× (currently)If we apply a justified range of 9–15× (based on peers), we get a fair value band = ₹350–₹590 crore market cap equivalent →₹340–₹570 per share.
(c) DCF Snapshot:Assuming 20% CAGR for 5 years and 12% discount rate, fair intrinsic range =₹500–₹800/share.
Educational Disclaimer:This fair value range is purely for learning purposes — not a stock tip. EduInvesting is not prescribing investment therapy.
6. What’s Cooking – News, Triggers, Drama
If there was a “Healthcare Startup of the Year” award, Unihealth would already be giving its acceptance speech.
- November 2025:H1 results showrevenue up 55%,profit up 195%, andEBITDA ₹35 crore. The newNavi Mumbai hospital is operational, adding an Indian feather to their African cap.
- September 2025:Announced200-bed UMC tertiary hospital in Nashikto be commissioned early 2026 — a move that could double domestic capacity.
- March–May 2025:Promoters infused₹10.57 crorevia7 lakh convertible warrantsat ₹151 each — classic sign of “we believe in our own stock” (and we like cheap entry).
- March 2025:Uganda subsidiaryVictoria Hospital JVgranted10-year corporate tax holiday— a fiscal miracle that every CFO dreams of.
- March 2025:Launched high-techIVF & Fertility Centre at

